ATE283917T1 - Agouti verwandtes gen - Google Patents

Agouti verwandtes gen

Info

Publication number
ATE283917T1
ATE283917T1 AT97918802T AT97918802T ATE283917T1 AT E283917 T1 ATE283917 T1 AT E283917T1 AT 97918802 T AT97918802 T AT 97918802T AT 97918802 T AT97918802 T AT 97918802T AT E283917 T1 ATE283917 T1 AT E283917T1
Authority
AT
Austria
Prior art keywords
art
gen
disclosed
agouti related
adrenal
Prior art date
Application number
AT97918802T
Other languages
English (en)
Inventor
Kevin Lee Stark
Roland Luethy
Original Assignee
Amgen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amgen Inc filed Critical Amgen Inc
Application granted granted Critical
Publication of ATE283917T1 publication Critical patent/ATE283917T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
AT97918802T 1996-05-10 1997-04-22 Agouti verwandtes gen ATE283917T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1750596P 1996-05-10 1996-05-10
US08/757,541 US5766877A (en) 1996-05-10 1996-11-27 Genes encoding art, an agouti-related transcript
PCT/US1997/006853 WO1997043412A1 (en) 1996-05-10 1997-04-22 Novel agouti-related gene

Publications (1)

Publication Number Publication Date
ATE283917T1 true ATE283917T1 (de) 2004-12-15

Family

ID=26689965

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97918802T ATE283917T1 (de) 1996-05-10 1997-04-22 Agouti verwandtes gen

Country Status (12)

Country Link
US (5) US5766877A (de)
EP (1) EP0917571B1 (de)
JP (1) JP4219404B2 (de)
AT (1) ATE283917T1 (de)
AU (1) AU2681497A (de)
CA (1) CA2253238C (de)
DE (1) DE69731834T2 (de)
DK (1) DK0917571T3 (de)
ES (1) ES2234015T3 (de)
PT (1) PT917571E (de)
SI (1) SI0917571T1 (de)
WO (1) WO1997043412A1 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5789651A (en) * 1993-05-21 1998-08-04 Martin Marietta Energy Systems, Inc. Isolation and characterization of Agouti: a diabetes/obesity related gene
US6310034B1 (en) 1993-05-21 2001-10-30 Ut-Battelle, Llc Agouti polypeptide compositions
WO2002064091A2 (en) * 2001-02-13 2002-08-22 Palatin Technologies, Inc. Melanocortin metallopeptides for treatment of sexual dysfunction
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript
AU5243798A (en) * 1996-11-06 1998-05-29 Children's Medical Center Corporation Transgenic animal expressing a syndecan in the regions of hypothalamus
EP1040351B1 (de) * 1997-12-16 2007-07-18 Merck & Co., Inc. C-terminale region des "agouti-related-transcript"-proteins (art)
US6878520B1 (en) * 1997-12-16 2005-04-12 Merck & Co., Inc. C-terminal region of agouti-related transcript (ART) protein
WO1999050295A2 (en) * 1998-03-30 1999-10-07 Gryphon Sciences Agouti-related protein analogs and methods of use
US6689873B1 (en) 1998-04-29 2004-02-10 Merck & Co., Inc. Nucleic acid encoding rat agouti related protein
WO2000014115A1 (en) * 1998-09-03 2000-03-16 Millennium Pharmaceuticals, Inc. Mc4-r as target for the identification of compounds used to treat drug addiction
US6716810B1 (en) * 1998-12-09 2004-04-06 Eleanor Roosevelt Institute Composition and method for regulation of body weight and associated conditions
US6603058B1 (en) 1998-12-09 2003-08-05 Oklahoma Medical Research Foundation Non-human animal model for obesity and uses thereof
US6303749B1 (en) 1999-01-29 2001-10-16 Amgen Inc. Agouti and agouti-related peptide analogs
US20030064921A1 (en) * 1999-10-27 2003-04-03 The Regents Of The University Of California Methods and compounds for modulating melanocortin receptor ligand binding and activity
EP1125579A3 (de) 2000-01-18 2003-01-02 Pfizer Products Inc. Verwendungen von AGRP-Melanocortinrezeptorbindung modulierenden Verbindungen
AU7507001A (en) * 2000-05-31 2001-12-11 Du Pont Catalysts for olefin polymerization
EP1385823B1 (de) 2001-04-09 2006-12-13 Chiron Corporation Guanidinoverbindungen als melanocortin-4-rezeptor (mc4-r) agonisten
US20030207814A1 (en) * 2002-02-04 2003-11-06 Chiron Corporation Novel guanidinyl derivatives
US20030195187A1 (en) * 2002-02-04 2003-10-16 Chiron Corporation Guanidino compounds
US20050124652A1 (en) * 2002-02-04 2005-06-09 Rustum Boyce Guanidino compounds
WO2003072056A2 (en) * 2002-02-25 2003-09-04 Chiron Corporation Intranasal administration of mc4-r agonists
JP2005531583A (ja) 2002-05-23 2005-10-20 カイロン コーポレイション 置換キナゾリノン化合物
WO2004004447A2 (en) * 2002-07-03 2004-01-15 Merck & Co., Inc. Agouti-related protein deficient cells, non-human transgenic animals and methods of selecting compounds which regulate energy metabolism
JP2007501861A (ja) * 2003-05-23 2007-02-01 カイロン コーポレイション Ｍｃ４−ｒアゴニストとしてのグアニジノ置換キナゾリノン化合物
US20060173167A1 (en) * 2003-08-13 2006-08-03 Gunter Stempfer Process for the purification of recombinant polypeptides
MXPA06005736A (es) * 2003-11-19 2006-12-14 Chiron Corp Compuestos de quinazolinona con bioacumulacion reducida.
US6974187B2 (en) * 2004-01-28 2005-12-13 Tachi-S Co., Ltd. Vehicle seat structure
EP1753735A1 (de) * 2004-04-20 2007-02-21 Transtech Pharma, Inc. Substituierte thiazol- und pyrimidinderivate als modulatoren des melanocortinrezeptors
US7910101B2 (en) 2004-10-25 2011-03-22 Centocor, Inc. Melanocortin receptor binding mimetibodies, compositions, methods and uses
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US7833927B2 (en) * 2005-08-31 2010-11-16 Rohm And Haas Company Single site palladium catalyst complexes
WO2010025142A1 (en) * 2008-08-29 2010-03-04 Transtech Pharma, Inc. Substituted aminothiazole derivatives, pharmaceutical compositions, and methods of use
CA2825098C (en) 2011-01-27 2020-03-10 Universite De Montreal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773919A (en) * 1969-10-23 1973-11-20 Du Pont Polylactide-drug mixtures
US4263428A (en) * 1978-03-24 1981-04-21 The Regents Of The University Of California Bis-anthracycline nucleic acid function inhibitors and improved method for administering the same
EP0052322B1 (de) * 1980-11-10 1985-03-27 Gersonde, Klaus, Prof. Dr. Verfahren zur Herstellung von Lipid-Vesikeln durch Ultraschallbehandlung, Anwendung des Verfahrens und Vorrichtung zur Durchführung des Verfahrens
IE52535B1 (en) * 1981-02-16 1987-12-09 Ici Plc Continuous release pharmaceutical compositions
DE3374837D1 (en) * 1982-02-17 1988-01-21 Ciba Geigy Ag Lipids in the aqueous phase
US4615885A (en) * 1983-11-01 1986-10-07 Terumo Kabushiki Kaisha Pharmaceutical composition containing urokinase
DE3572982D1 (en) * 1984-03-06 1989-10-19 Takeda Chemical Industries Ltd Chemically modified lymphokine and production thereof
EP0401384B1 (de) * 1988-12-22 1996-03-13 Kirin-Amgen, Inc. Chemisch modifizierte granulocytenkolonie erregender faktor
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
US5766877A (en) * 1996-05-10 1998-06-16 Amgen Inc. Genes encoding art, an agouti-related transcript

Also Published As

Publication number Publication date
EP0917571A1 (de) 1999-05-26
CA2253238A1 (en) 1997-11-20
US7122520B2 (en) 2006-10-17
US5766877A (en) 1998-06-16
DE69731834D1 (de) 2005-01-05
SI0917571T1 (en) 2005-06-30
AU2681497A (en) 1997-12-05
PT917571E (pt) 2005-04-29
JP2001517931A (ja) 2001-10-09
US20010007752A1 (en) 2001-07-12
WO1997043412A1 (en) 1997-11-20
CA2253238C (en) 2008-08-12
DE69731834T2 (de) 2005-12-15
US6203995B1 (en) 2001-03-20
EP0917571B1 (de) 2004-12-01
ES2234015T3 (es) 2005-06-16
US20030082737A1 (en) 2003-05-01
JP4219404B2 (ja) 2009-02-04
DK0917571T3 (da) 2005-03-14
US6060589A (en) 2000-05-09

Similar Documents

Publication Publication Date Title
ATE283917T1 (de) Agouti verwandtes gen
ZA967173B (en) Purified coprinus laccases and nucleic acids and encoding same
WO2001018172A3 (en) Fibroblast growth factor-like polypeptides
DE60033138D1 (de) Polypeptide mit galaktoseoxidaseaktivität und dafür kodierende nukleisäuren
WO2002031134A3 (en) Novel serine protease genes related to dppiv
WO2000073348A3 (en) Methods and compositions for inhibiting neoplastic cell growth
WO2001029222A3 (en) Polypeptides having phospholipase b activity and nucleic acids encoding same
DE69930955D1 (de) Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
DK0981630T3 (da) Polypeptider med prolyldipeptidylaminopeptidaseaktivitet og nukleinsyrer, der koder for samme
WO2003089598A3 (en) Polypeptides having xyloglucanase activity and nucleic acids encoding same
ATE309353T1 (de) Verfahren zur herstellung von rekombinanten peptiden
AU3802595A (en) Tripeptidyl aminopeptidase
MX9602977A (es) Proteinas que reparan la mala union de adn humano.
AU7489098A (en) Polypeptides having aminopeptidase activity and nucleic acids encoding same
HUP9904414A2 (hu) A neuritin neurogén
AU2001238064A1 (en) 18477, a human protein kinase and uses therefor
WO2000028043A3 (en) Polypeptides having lactonohydrolase activity and nucleic acids encoding same
DE69934017D1 (de) 2,6-beta-d-fruktanhydrolase enzym und verfahren zu dessen verwendung
WO2000041509A3 (en) Polypeptides having acid phosphatase activity and nucleic acids encoding same
WO2000044898A3 (en) Novel agouti and agouti-related peptide analogs
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
AU7645400A (en) Polypeptides having glucanotransferase activity and nucleic acids encoding same
WO1999050288A3 (en) Mammalian blood loss-induced gene, kd312
DE69636737D1 (de) Neues immunoregulatorisches protein lst-1
WO2000031241A3 (en) Polypeptides having choline oxidase activity and nucleic acids encoding same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0917571

Country of ref document: EP

REN Ceased due to non-payment of the annual fee